Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 651-675 of 753 matching filings.

Per page
25
Current page
27
8-K File 001-15697

8-K

Filing date
09 Jan 2012
Reporting date
05 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

CURRENT REPORT

Filing date
05 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-15697

CT ORDER filing

Filing date
29 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
19 Oct 2011
Reporting date
18 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
27 Sep 2011
Reporting date
26 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-15697

CT ORDER filing

Filing date
22 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59693

AMENDMENT TO SCHEDULE 13G

Filing date
19 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-15697

DEF 14A

Filing date
31 Aug 2011
Reporting date
18 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
31 Aug 2011
Reporting date
31 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-15697

CT ORDER filing

Filing date
31 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
17 Aug 2011
Reporting date
12 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-15697

FORM 10-Q

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-15697

PRE 14A filing

Filing date
28 Jul 2011
Reporting date
28 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59693

AMENDMENT TO SCHEDULE 13G

Filing date
07 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-15697

FORM 10-K

Filing date
29 Jun 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
29 Jun 2011
Reporting date
23 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

CURRENT REPORT

Filing date
07 Jun 2011
Reporting date
01 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

CURRENT REPORT

Filing date
06 Jun 2011
Reporting date
31 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59693

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
03 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-59693

AMENDMENT NO. 3 TO SCHEDULE 13D

Filing date
26 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2011
Reporting date
24 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
24 May 2011
Reporting date
24 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-59693

SCHEDULE 13D

Filing date
24 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .